Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 3Phase NA 2Phase 1/2 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 2

Interventions

Cyclophosphamide 34Cytarabine 33Exercise 26Blood Specimen Collection 24venetoclax 23fludarabine phosphate 22Busulfan 22fludarabine 18Methotrexate 18Methods 18Cyclosporine 18Peripheral Blood Stem Cell Transplantation 17Filgrastim 17Antilymphocyte Serum 17Standard of Care 16Whole-Body Irradiation 15Granulocyte Colony-Stimulating Factor 15Educational Status 15Early Intervention, Educational 15Palliative Care 14Melphalan 14Daunorubicin 14Mycophenolic Acid 13Azacitidine 13Practice Guidelines as Topic 12Etoposide 12Dexamethasone 12Radiotherapy 11Interviews as Topic 10Vincristine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Aclarubicin × Other hematologic neoplasm × Clear all
NCT05258799 2022-02-28

Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter Study

Shengjing Hospital

Phase NA Unknown
130 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04168138 2019-11-19

D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients

Shengjing Hospital

Phase NA Unknown
20 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡